Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Pharm Biol ; 50(11): 1436-41, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22950673

ABSTRACT

CONTEXT: Annona muricata Linn (Annonaceae) (soursop) is a food plant reported to have antihypertensive properties. OBJECTIVE: We investigated the blood pressure reducing effect of its aqueous leaf extract and the possible mechanisms that may be responsible. METHODS: Intravenous administration of an aqueous leaf extract (9.17-48.5 mg/kg) of A. muricata on the mean arterial pressure and heart rate were recorded invasively on anaesthetized, normotensive Sprague-Dawley rats. Contractile responses of rat aortic rings to the extract (0.5-4.0 mg/mL) were studied using standard organ bath techniques. RESULTS: A. muricata (9.17-48.5 mg/kg) caused significant (p < 0.05) dose-dependent reduction in blood pressure without affecting the heart rates. The hypotensive effects were unaffected by atropine (2 mg/kg), mepyramine (5 mg/kg), propranolol (1 mg/kg) and L-NAME (5 mg/kg). A. muricata leaf aqueous extract significantly (p < 0.05) relaxed phenylephrine (10(-9)-10(-4) M) and 80 mM KCl induced contractions in endothelium intact and denuded aortic rings; and caused a significant (p < 0.05) rightward shift of the Ca(2+) dose response curves in Ca(2+)-free Kreb's solution containing 0.1 mM EGTA. CONCLUSIONS: The hypotensive effects of A. muricata are not mediated through muscarinic, histaminergic, adrenergic and nitric oxide pathways, but through peripheral mechanisms involving antagonism of Ca(2+).


Subject(s)
Annona/chemistry , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Heart Rate/drug effects , Animals , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/isolation & purification , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Calcium/metabolism , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Male , Muscle Contraction/drug effects , Plant Leaves , Rats , Rats, Sprague-Dawley
2.
Pharm Biol ; 50(9): 1096-102, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22830437

ABSTRACT

CONTEXT AND OBJECTIVES: Artocarpus altilis (Parkinson) Fosberg (Moraceae) (breadfruit) leaves are used as an antihypertensive remedy. We investigated the possible mechanisms of action of its aqueous extract and its effect on cytochromes P450 (CYP) enzyme activities. MATERIALS AND METHODS: Intravenous administration of an aqueous leaf extract (20.88-146.18 mg/kg) of A. altilis on mean arterial pressure and heart rate were recorded via cannulation of the carotid artery on anaesthetized normotensive Sprague-Dawley rats. Recordings of the contractile activity of the aortic rings to the extract (0.71-4.26 mg/mL) were studied using standard organ bath techniques. Inhibitions of human CYP3A4 and CYP2D6 enzyme activities were evaluated by means of a fluorometric assay in 96 well plates using heterologously expressed microsomes. RESULTS: A. altilis caused significant (p < 0.05) hypotensive and bradycardiac responses unaffected by atropine (2 mg/kg) and mepyramine (5 mg/kg), but attenuated by propranolol (1 mg/kg) and N(G)-nitro-L-arginine methyl ester (5 mg/kg). The extract (0.71-4.26 mg/mL) significantly (p < 0.05) relaxed phenylephrine (10⁻9-10⁻4 M) and 80 mM KCl-induced contractions in endothelium intact and denuded aortic rings; and caused a significant (p < 0.05) rightward shift of the Ca²âº dose-response curves in Ca²âº-free Kreb's solution. Moderate inhibitions of cytochrome P450s (CYP3A4 and CYP2D6) enzyme activities with IC50 values of 0.695 ± 0.187 and 0.512 ± 0.131 mg/mL, respectively, were produced. CONCLUSION: A. altilis exhibits negative chronotropic and hypotensive effects through α-adrenoceptor and Ca²âº channel antagonism. Drug adversity effects are unlikely if the aqueous leaf extract is consumed with other medications reliant on CYP3A4 and CYP2D6 metabolism. This study thus provides scientific evidence for the use of the breadfruit in the treatment of hypertension.


Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Antihypertensive Agents/pharmacology , Artocarpus/chemistry , Calcium Channel Blockers/pharmacology , Muscle, Smooth, Vascular/drug effects , Plant Extracts/pharmacology , Plant Leaves/chemistry , Adrenergic alpha-Antagonists/administration & dosage , Animals , Antihypertensive Agents/administration & dosage , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors , Aryl Hydrocarbon Hydroxylases/genetics , Aryl Hydrocarbon Hydroxylases/metabolism , Calcium Channel Blockers/administration & dosage , Cytochrome P-450 CYP2D6/genetics , Cytochrome P-450 CYP2D6/metabolism , Cytochrome P-450 CYP2D6 Inhibitors , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Ethnopharmacology , Humans , In Vitro Techniques , Jamaica , Male , Muscle, Smooth, Vascular/metabolism , Plant Extracts/administration & dosage , Rats , Rats, Sprague-Dawley , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/metabolism , Vasodilator Agents/administration & dosage , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL